Latest Breaking News On - காத்தாடி பார்மா - Page 4 : comparemela.com

ADVERTISEMENT Fed. Circ. Judge Unsure IP At Heart Of $1.1B Juno Win Is Valid Law360 (July 6, 2021, 8:46 PM EDT) The Federal Circuit s chief judge appeared receptive Tuesday to Kite Pharma s argument that a Juno Therapeutics drug patent is too broad to be valid, potentially calling into question Juno s more than $1.1 billion infringement win during the appellate court s first in-person hearing since the arrival of the COVID-19 pandemic. The three-judge panel was considering Kite Pharma Inc. s appeal of a California federal judge s final judgment, which tacked $389 million in enhanced damages onto a $752 million jury verdict that found Kite willfully infringed Juno s patent with its own immunotherapy cancer drug, Yescarta.

United statesKite pharma incFederal circuitKite pharmaJuno therapeuticsஒன்றுபட்டது மாநிலங்களில்காத்தாடி பார்மா இன்க்கூட்டாட்சியின் சுற்றுகாத்தாடி பார்மாஜூனோ சிகிச்சை